BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 6773986)

  • 21. Induction of apoptosis in human replicative senescent fibroblasts.
    DeJesus V; Rios I; Davis C; Chen Y; Calhoun D; Zakeri Z; Hubbard K
    Exp Cell Res; 2002 Mar; 274(1):92-9. PubMed ID: 11855860
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Glucose controls cathepsin expression in Ras-transformed fibroblasts.
    Tournu C; Obled A; Roux MP; Deval C; Ferrara M; Béchet DM
    Arch Biochem Biophys; 1998 Dec; 360(1):15-24. PubMed ID: 9826424
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cathepsin B activity in B16 melanoma cells: a possible marker for metastatic potential.
    Sloane BF; Honn KV; Sadler JG; Turner WA; Kimpson JJ; Taylor JD
    Cancer Res; 1982 Mar; 42(3):980-6. PubMed ID: 7059993
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Demonstration of cathepsins B, H and L in xenografts of normal and Duchenne-muscular-dystrophy muscles transplanted into nude mice.
    Takeda A; Jimi T; Wakayama Y; Misugi N; Miyake S; Kumagai T
    Biochem J; 1992 Dec; 288 ( Pt 2)(Pt 2):643-8. PubMed ID: 1463465
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Regulation of dipeptidyl aminopeptidase I and angiotensin converting enzyme activities in cultured murine brain cells by cortisol and thyroid hormone.
    Davis MH; Pieringer J
    J Neurochem; 1987 Feb; 48(2):447-54. PubMed ID: 3025371
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Alterations in creatine kinase in fresh muscle and cell cultures in Duchenne dystrophy.
    Ionasescu V; Ionasescu R; Feld R; Witte D; Cancilla P; Kaeding L; Stern LZ
    Ann Neurol; 1981 Apr; 9(4):394-9. PubMed ID: 7224603
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Effect of choriogonine on the enzymatic activity of lysosomes in the cirrhotic liver in the rat].
    Blinova TV; Solopaeva IM; Zharikova GV
    Vopr Med Khim; 1982; 28(6):41-5. PubMed ID: 6818764
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Decreased apoptotic response of inclusion-cell disease fibroblasts: a consequence of lysosomal enzyme missorting?
    Terman A; Neuzil J; Kågedal K; Ollinger K; Brunk UT
    Exp Cell Res; 2002 Mar; 274(1):9-15. PubMed ID: 11855852
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An in situ study of beta-glucosidase activity in normal and Gaucher fibroblasts with fluorogenic probes.
    Kohen E; Kohen C; Hirschberg JG; Santus R; Grabowski G; Mangel W; Gatt S; Prince J
    Cell Biochem Funct; 1993 Sep; 11(3):167-77. PubMed ID: 8403230
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Skeletal muscle of patients with Duchenne's muscular dystrophy: evidence of a mitochondrial proteolytic factor responsible for calmitine deficiency.
    Lucas-Heron B
    Biochem Biophys Res Commun; 1996 Jun; 223(1):31-5. PubMed ID: 8660374
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Degradation of apolipoprotein B-100 by lysosomal cysteine cathepsins.
    Linke M; Gordon RE; Brillard M; Lecaille F; Lalmanach G; Brömme D
    Biol Chem; 2006 Sep; 387(9):1295-303. PubMed ID: 16972799
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lysosomal enzyme activities: new potential markers for Sjögren's syndrome.
    Sohar N; Sohar I; Hammer H
    Clin Biochem; 2005 Dec; 38(12):1120-6. PubMed ID: 16257401
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Properties of dipeptidyl peptidase I from rabbit (Oryctolagus cuniculus) lungs.
    Paszkowski A; Singh H; Kalnitsky G
    Acta Biochim Pol; 1983; 30(3-4):363-80. PubMed ID: 6673427
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gallic acid prevents lysosomal damage in isoproterenol induced cardiotoxicity in Wistar rats.
    Stanely Mainzen Prince P; Priscilla H; Devika PT
    Eur J Pharmacol; 2009 Aug; 615(1-3):139-43. PubMed ID: 19450577
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Duchenne's muscular dystrophy: studies in cultured fibroblasts.
    Wyatt PR; Cox DM
    Lancet; 1977 Jan; 1(8004):172-4. PubMed ID: 64702
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of beta-galactosidase mutations Asp332-->Asn and Arg148-->Ser, and a polymorphism, Ser532-->Gly, in a case of GM1 gangliosidosis.
    Zhang S; Bagshaw R; Hilson W; Oho Y; Hinek A; Clarke JT; Callahan JW
    Biochem J; 2000 Jun; 348 Pt 3(Pt 3):621-32. PubMed ID: 10839995
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A drug inhibits the mitochondrial protease inducing calmitine deficiency in skeletal muscle of patients with Duchenne's muscular dystrophy and dy/dy dystrophic mice.
    Lucas-Heron B
    Biochem Biophys Res Commun; 1997 Mar; 232(2):559-61. PubMed ID: 9125222
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Influence of bioflavonoids on lysosomal acid hydrolases and lysosomal stability.
    Rao CN; Rao VH; Steinmann B
    Ital J Biochem; 1981; 30(1):46-53. PubMed ID: 7251340
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lysosomal peptidases and glycosidases in rheumatoid arthritis.
    Sohar N; Hammer H; Sohar I
    Biol Chem; 2002 May; 383(5):865-9. PubMed ID: 12108554
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Abnormal growth kinetics and 5'-nucleotidase activities in cultured skin fibroblasts from patients with Duchenne muscular dystrophy.
    Liechti-Gallati S; Moser H; Siegrist HP; Wiesmann U; Herschkowitz NN
    Pediatr Res; 1981 Nov; 15(11):1411-4. PubMed ID: 6272184
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.